Latest Announcements

Quint Digital Ltd has amended its Articles of Association, allowing lenders to nominate directors to the company's board. The amendment was approved by the company's members at the 41st Annual General Meeting. The change gives lenders the right to nominate observers or directors to attend and participate in board meetings, subject to the terms of the relevant financing documents.

Happiest Minds Technologies Limited has informed the Exchange about the approval of the Scheme of Arrangement by the Hon'ble National Company Law Tribunal, Bengaluru Bench. The Scheme involves the amalgamation of Aureustech Systems Private Limited and Happiest Minds Technologies Limited, and their respective Shareholders and Creditors. The Appointed Date for the merger is April 1, 2026.

Happiest Minds Technologies Ltd has received the certified true copy of the final order from the Hon'ble National Company Law Tribunal, Bengaluru Bench, approving the Scheme of Amalgamation of Aureustech Systems Private Limited and Happiest Minds Technologies Limited.

Fine Organic Industries Limited has informed the Exchange about updates on Acquisitions, specifically the completion of the acquisition of 80% of the paid-up capital of Oleofine Organics SDN. BHD. in Malaysia, which is now proposed to be completed within the next 3 months due to certain procedural requirements.

Fine Organic Industries Ltd has extended the timeline for the completion of its acquisition of 80% of the paid-up capital of Oleofine Organics SDN. BHD. from 3 months to 6 months due to certain procedural requirements.

Repro India Ltd has announced the acquisition of 100% shares of Repro LLC, a distribution company for books, through its subsidiary Repro Books Limited. The acquisition is subject to regulatory approvals and is expected to be completed by August 31, 2026. The consideration is AED 10,000, and Repro India Ltd will acquire 100% of the equity shares.

Repro India Limited has informed the Exchange about the acquisition of 100% equity shares of Repro LLC, a UAE-based company, for a cash consideration of AED 10,000. The acquisition is expected to strengthen the Company's presence and business operations in the UAE and support its organic growth strategy.

Jubilant Ingrevia Limited has entered into a binding agreement with Zettaone Technologies India Pvt Ltd to acquire a 40% strategic stake for INR 189.2 crore, aligning with its Pinnacle growth strategy and expanding its presence in the Electronics Development and Manufacturing Services (EDMS) space.

Jubilant Ingrevia Ltd has entered into a binding term sheet with Zettaone Technologies India Private Limited for the acquisition of a 40% strategic equity stake in Zettaone for ₹189.2 Cr. The acquisition is aligned with the company's Pinnacle growth strategy and will enable Jubilant Ingrevia to deliver an integrated value proposition in electronics and semi-conductor space.

Ugro Capital Limited has informed the Exchange about Amalgamation/Merger. The company has scheduled a meeting of the Equity Shareholders to consider and approve the Scheme of Amalgamation of Profectus Capital Private Limited with UGRO Capital Limited and their respective shareholders and creditors.

Ugro Capital Ltd has announced the convening of separate meetings of equity shareholders, secured creditors, and unsecured creditors for the purpose of considering and approving the proposed scheme of amalgamation with Profectus Capital Private Limited, as per the directions of the National Company Law Tribunal.

HEG Limited has informed the Exchange about the sanctioning of a Composite Scheme of Arrangement amongst HEG Limited, HEG Graphite Limited, and Bhilwara Energy Limited, as per the order passed by the National Company Law Tribunal, Indore Bench, on August 13, 2026.

HEG Limited has informed the Exchange about the sanctioning of a Composite Scheme of Arrangement amongst HEG Limited, HEG Graphite Limited, and Bhilwara Energy Limited by the Hon'ble National Company Law Tribunal, Indore Bench.

HEG Ltd has received approval from the National Company Law Tribunal (NCLT) for a composite scheme of arrangement involving HEG Ltd, HEG Graphite Ltd, and Bhilwara Energy Ltd. The scheme involves the demerger of HEG Ltd's graphite business into HEG Graphite Ltd, and the transfer of certain assets and liabilities to Bhilwara Energy Ltd. The scheme is subject to the receipt of a certified copy of the NCLT order and the filing of the same with the Registrar of Companies.

BLS International Services Limited has informed the Exchange about the merger of its step-down subsidiary, BLS International Vize Hizmetleri Limited Sirketi, with another step-down subsidiary, iDATA Danismanlik Ve Hizmet Dis Tic AS, with effect from August 17, 2026.

BLS International Services Ltd has informed that its step-down subsidiary, BLS International Vize Hizmetleri Limited Sirketi, has merged into another step-down subsidiary, iDATA Danismanlik Ve Hizmet Dis Tic AS, with effect from August 17, 2026. The merger was done on an arm's length basis and does not involve any cash consideration or issuance of new shares.

Virat Industries Ltd has announced a meeting with analysts/institutional investors/public to discuss the proposal for acquisition of stake in Brahm Lifestyle Products Private Limited. The meeting will be held on August 21, 2026, via conference call. The company will not disclose any unpublished price sensitive information during the meeting.

Blue Blends (I) Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026, where the Board approved the cancellation and extinguishment of existing equity shares held by promoters and public shareholders, and allotment of fresh equity shares on preferential basis.

Alivus Life Sciences Limited has announced the acquisition of a 76% stake in IQGenX Pharma Private Limited for a consideration of INR 91.2 million. The acquisition will enable Alivus to leverage its core portfolio selectively into advanced formulation development and expand its global customer base in the generic pharmaceutical segment.

Alivus Life Sciences Ltd has announced the acquisition of a 76% stake in IQGenX Pharma Private Limited for a consideration of INR 91.2 million. The acquisition will enable Alivus to leverage its core portfolio selectively into advanced formulation development and expand its global customer base in the generic pharmaceutical segment.